Min Xie

Prof. Dr. Min Xie

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
XLXiaochen Li
Xiaochen Li
SXShuyun Xu
Shuyun Xu
MYMuqing Yu
Muqing Yu
KWKe Wang
Ke Wang
YTYu Tao
Yu Tao
JZJianping Zhao
Jianping Zhao

19 February 2020 in BMJ
Verified
Journal Article
Open access
PDF file
XLXiaochen Li
Xiaochen Li
XCXiaopei Cao
Xiaopei Cao
MGMingzhou Guo
Mingzhou Guo
MXMin Xie
Min Xie
XLXiansheng Liu
Xiansheng Liu
Objective To describe the temporal and spatial trends of mortality and disability adjusted life years (DALYs) due to chronic respiratory diseases, by age and sex, across the world during 1990-2017 using data from the Global Burden of Disease Study 2017. Design Systematic analysis. Data source The Global Burden of Diseases, Injuries, and Risk Factors Study 2017. Methods Mortality and DALYs from chronic respiratory diseases were estimated from the Global Burden of Disease Study 2017 using DisMod-MR 2.1, a Bayesian meta-regression tool. The estimated annual percentage change of the age standardised mortality rate was calculated using a generalised linear model with a Gaussian distribution. Mortality and DALYs were stratified according to the Socio-demographic index. The strength and direction of the association between the Socio-demographic index and mortality rate were measured using the Spearman rank order correlation. Risk factors for chronic respiratory diseases were analysed from exposure data. Results Between 1990 and 2017, the total number of deaths due to chronic respiratorydiseases increased by 18.0%, from 3.32 (95% uncertainty interval 3.01 to 3.43) million in 1990 to 3.91 (3.79 to 4.04) million in 2017. The age standardised mortality rate of chronic respiratory diseases decreased by an average of 2.41% (2.28% to 2.55%) annually. During the 27 years, the annual decline in mortality rates of chronic obstructive pulmonary disease (COPD; 2.36%, uncertainty interval 2.21% to 2.50%) and pneumoconiosis (2.56%, 2.44% to 2.68%) has been slow, whereas the mortality rate for interstitial lung disease and pulmonary sarcoidosis (0.97%, 0.92% to 1.03%) has increased. Reductions in DALYs for asthma and pneumoconiosis have been seen, but DALYs due to COPD, and interstitial lung disease and pulmonary sarcoidosis have increased. Mortality and the annual change in mortality rate due to chronic respiratory diseases varied considerably across 195 countries. Assessment of the factors responsible for regional variations in mortality and DALYs and the unequal distribution of improvements during the 27 years showed negative correlations between the Socio-demographic index and the mortality rates of COPD, pneumoconiosis, and asthma. Regions with a low Socio-demographic index had the highest mortality and DALYs. Smoking remained the major risk factor for mortality due to COPD and asthma. Pollution from particulate matter was the major contributor to deaths from COPD in regions with a low Socio-demographic index. Since 2013, a high body mass index has become the principal risk factor for asthma. Conclusions Regions with a low Socio-demographic index had the greatest burden of disease. The estimated contribution of risk factors (such as smoking, environmental pollution, and a high body mass index) to mortality and DALYs supports the need for urgent efforts to reduce exposure to them.

11 February 2020 in Respiratory Research
Verified
Journal Article
Open access
PDF file
MXMin Xie
Min Xie
XLXiansheng Liu
Xiansheng Liu
XCXiaopei Cao
Xiaopei Cao
MGMingzhou Guo
Mingzhou Guo
XLXiaochen Li
Xiaochen Li
Background: Chronic respiratory diseases (CRDs) are leading causes of morbidity worldwide. However, the spatial and temporal trends in prevalence and incidence of CRDs have not been estimated. Methods: Based on data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2017, we analyzed the prevalence and incidence trends of CRDs from 1990 to 2017 according to age, sex, region and disease pattern. Furthermore, the correlations between the incidence and the World Bank income levels, sociodemographic index (SDI), and human development index (HDI) levels were analyzed to assess the factors affecting incidence. Result: The total number of CRD cases increased by 39.5% from 1990 to 2017, nevertheless, the age-standardized prevalence rate (ASPR) and age-standardized incidence rate (ASIR) showed decreasing trends. The ASIRs of CRD, chronic obstructive pulmonary disease (COPD), pneumoconiosis, and asthma decreased, whereas the ASIR of interstitial lung disease and pulmonary sarcoidosis increased during the past 27 years. Significant differences between males and females in the incidence rates of pneumoconiosis, interstitial lung disease and pulmonary sarcoidosis were observed. Elderly people especially suffered from CRDs, except for asthma. For COPD, the ASIR decreased from low-SDI regions to high-SDI regions. The ASIR of interstitial lung disease and pulmonary sarcoidosis in the high-SDI region was highest and have increased mostly. The ASIRs for pneumoconiosis and asthma were inversely related to the HDI. Conclusions: In 2017, CRDs were still the leading causes of morbidity worldwide. A large proportion of the disease burden was attributed to asthma and COPD. The incidence rates of all four types of CRDs varied greatly across the world. Statistically significant correlation was found between the ASIR and SDI/HDI.

4 June 2020 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
LQLu Qin
Lu Qin
XLXiaochen Li
Xiaochen Li
JSJing Shi
Jing Shi
MYMuqing Yu
Muqing Yu
KWKe Wang
Ke Wang
MXMin Xie
Min Xie

23 April 2020 in Intensive Care Medicine
Verified
Journal Article
Open access
PDF file
KWKe Wang
Ke Wang
ZZZhiguo Zhang
Zhiguo Zhang
MYMuqing Yu
Muqing Yu
YTYu Tao
Yu Tao
MXMin Xie
Min Xie

1 February 2017 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
YHYuanzhou He
Yuanzhou He
XCXiaopei Cao
Xiaopei Cao
PGPujian Guo
Pujian Guo
XLXiaochen Li
Xiaochen Li
HSHuihui Shang
Huihui Shang
XLXiansheng Liu
Xiansheng Liu